Financials
Financial year 2025
Gross margin
€ 852,996
▼ 21% vs 2024
Profit
Healthy€ 349,051
▼ 50% vs 2024
Debts
High€ 1.1 million
▲ 1002% vs 2024
STUDIO PHARMA from Aalter, company number BE0883309219, closed financial year 2025 with a result of € 349,051 after tax. For that financial year STUDIO PHARMA recorded a gross margin of € 852,996 and equity of € 138,700. Compared with financial year 2024, the result moved from € 694,614 to € 349,051. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.
What happened at STUDIO PHARMA?
What happened at STUDIO PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 349,051 (▼ 50% vs 2024). Source: NBB ↗
- Ter Loonst BV became a director. NBB
- Patrick Van Dooren became a director. NBB
- Jeremy Dielen became a director. NBB
- Emmanuel Vanderhaegen became a director. NBB
- New establishment in Gent. KBO
- New establishment in Aalter. KBO
- Start of the company according to the CBE. KBO
In short
From € 206,506 profit in 2021 to € 349,051 profit in 2025.
Paid € 722,195 in corporate taxes since 2021.
Best year ever: 2024, with € 694,614 profit.
On average € 174,100 of value added per employee in 2025.
A new publication or filing at STUDIO PHARMA? We notify you, reason included.
Follow STUDIO PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind STUDIO PHARMA are Patrick Van Dooren, Ter Loonst BV, Jeremy Dielen and Emmanuel Vanderhaegen. The same people are also behind KDT Consulting, IN2PHARMA, PHC Group, Arphius and C&N HOLDING.
Directors
According to the 2025 annual accounts
since 2026
Persoon belast met dagelijks bestuur · represented by Caroline Steensels
Also active at: Arphius, C&N HOLDING, KDT Consulting +1 more
since 2026
since 2026
since 2026
Establishments
Establishment units
Physical locations of this company
Artemeersstraat 11
9880 Aalter
Kerkstraat 108
9050 Gent
Active since 18 November 2021
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0883.309.219
- VAT number
- BE 0883.309.219
- Registered office
- Artemeersstraat 11, 9880 Aalter
- Names & denominations
- STUDIO PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 September 2006
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Public relationsbureaus
Adviesbureaus op het gebied van public relations en communicatie